Association of soluble Tumor necrosis factor-Related Apoptosis-Inducing Ligand (TRAIL) with central adiposity and low-density lipoprotein cholesterol.
<h4>Objective</h4>Tumor necrosis factor-Related Apoptosis-Inducing Ligand (TRAIL), in addition to having a prognostic value in patients with cardiovascular disease, seems to interact with adiposity, insulin resistance and other cardiovascular risk factors. However, the results of previou...
Guardado en:
Autores principales: | Gloria Brombo, Stefano Volpato, Paola Secchiero, Angelina Passaro, Cristina Bosi, Giovanni Zuliani, Giorgio Zauli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5d1185285d8945ad89862d4eb94df4e0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TRAIL/DR5 pathway promotes AKT phosphorylation, skeletal muscle differentiation, and glucose uptake
por: Barbara Toffoli, et al.
Publicado: (2021) -
Trail (TNF-related apoptosis-inducing ligand) induces an inflammatory response in human adipocytes
por: Verena Zoller, et al.
Publicado: (2017) -
Circulating TRAIL shows a significant post-partum decline associated to stressful conditions.
por: Giorgio Zauli, et al.
Publicado: (2011) -
Decreased high density lipoprotein cholesterol is an independent predictor for persistent organ failure, pancreatic necrosis and mortality in acute pancreatitis
por: Yushun Zhang, et al.
Publicado: (2017) -
TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis
por: Harsimran D. Singh, et al.
Publicado: (2017)